{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:52:13Z","timestamp":1786992733681,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-cardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.jjcc.2018.04.014","type":"journal-article","created":{"date-parts":[[2018,6,10]],"date-time":"2018-06-10T17:01:51Z","timestamp":1528650111000},"page":"466-472","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Modern treatment to reduce pulmonary arterial pressure in pulmonary arterial hypertension"],"prefix":"10.1016","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9392-7117","authenticated-orcid":false,"given":"Satoshi","family":"Akagi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8845-3626","authenticated-orcid":false,"given":"Kazufumi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jjcc.2018.04.014_bib0155","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"Galie","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2018.04.014_bib0160","article-title":"A comprehensive risk stratification at early follow-up determines prognosis in pulmonary arterial hypertension","author":"Kylhammar","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2018.04.014_bib0165","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.lfs.2014.01.077","article-title":"Long-term patient survival with idiopathic\/heritable pulmonary arterial hypertension treated at a single center in Japan","volume":"118","author":"Ogawa","year":"2014","journal-title":"Life Sci"},{"key":"10.1016\/j.jjcc.2018.04.014_bib0170","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1093\/eurheartj\/ehr160","article-title":"Early detection of pulmonary vascular disease in pulmonary arterial hypertension: time to move forward","volume":"32","author":"Lau","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2018.04.014_bib0175","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1172\/JCI33452","article-title":"Molecular pathogenesis of pulmonary arterial hypertension","volume":"118","author":"Rabinovitch","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jjcc.2018.04.014_bib0180","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S0022-5223(19)38415-6","article-title":"Reversibility of plexogenic pulmonary arteriopathy following banding of the pulmonary artery","volume":"87","author":"Wagenvoort","year":"1984","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jjcc.2018.04.014_bib0185","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S1053-2498(00)00153-4","article-title":"Pathologic regression of primary pulmonary hypertension in left native lung following right single-lung transplantation","volume":"20","author":"Levy","year":"2001","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jjcc.2018.04.014_bib0190","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/cvr\/cvw070","article-title":"Haemodynamic unloading reverses occlusive vascular lesions in severe pulmonary hypertension","volume":"111","author":"Abe","year":"2016","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jjcc.2018.04.014_bib0195","doi-asserted-by":"crossref","DOI":"10.1177\/2045893217741429","article-title":"Dual ETA\/ETB blockade with macitentan improves both vascular remodeling and angiogenesis in pulmonary arterial hypertension","volume":"8","author":"Nadeau","year":"2018","journal-title":"Pulm Circ"},{"key":"10.1016\/j.jjcc.2018.04.014_bib0200","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00395-004-0504-5","article-title":"Antiproliferative effect of sildenafil on human pulmonary artery smooth muscle cells","volume":"100","author":"Tantini","year":"2005","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.jjcc.2018.04.014_bib0205","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejphar.2017.06.010","article-title":"Tadalafil induces antiproliferation, apoptosis, and phosphodiesterase type 5 downregulation in idiopathic pulmonary arterial hypertension in vitro","volume":"810","author":"Yamamura","year":"2017","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jjcc.2018.04.014_bib0210","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1165\/ajrcmb.26.2.4695","article-title":"Differential effects of stable prostacyclin analogs on smooth muscle proliferation and cyclic AMP generation in human pulmonary artery","volume":"26","author":"Clapp","year":"2002","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jjcc.2018.04.014_bib0215","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1161\/01.CIR.102.25.3130","article-title":"Prostacyclin analogues differentially inhibit growth of distal and proximal human pulmonary artery smooth muscle cells","volume":"102","author":"Wharton","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2018.04.014_bib0220","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ijcard.2011.09.004","article-title":"Prostaglandin I2 induces apoptosis via upregulation of Fas ligand in pulmonary artery smooth muscle cells from patients with idiopathic pulmonary arterial hypertension","volume":"165","author":"Akagi","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jjcc.2018.04.014_bib0225","first-page":"173","article-title":"Reverse remodeling of pulmonary arteries by high-dose prostaglandin I2 therapy: a case report","volume":"9","author":"Akagi","year":"2014","journal-title":"J Cardiol Case"},{"key":"10.1016\/j.jjcc.2018.04.014_bib0230","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1183\/09031936.05.00075305","article-title":"Goal-oriented treatment and combination therapy for pulmonary arterial hypertension","volume":"26","author":"Hoeper","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jjcc.2018.04.014_bib0235","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1056\/NEJMoa1413687","article-title":"Initial use of ambrisentan plus tadalafil in pulmonary arterial hypertension","volume":"373","author":"Galie","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2018.04.014_bib0240","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/S2213-2600(16)30307-1","article-title":"Initial combination therapy with ambrisentan and tadalafil and mortality in patients with pulmonary arterial hypertension: a secondary analysis of the results from the randomised, controlled ambition study","volume":"4","author":"Hoeper","year":"2016","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jjcc.2018.04.014_bib0245","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1183\/09031936.00116313","article-title":"Upfront triple combination therapy in pulmonary arterial hypertension: a pilot study","volume":"43","author":"Sitbon","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jjcc.2018.04.014_bib0250","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1253\/circj.CJ-17-0139","article-title":"Effectiveness and outcome of pulmonary arterial hypertension-specific therapy in Japanese patients with pulmonary arterial hypertension","volume":"82","author":"Tamura","year":"2017","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2018.04.014_bib0255","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1161\/01.CIR.0000029100.82385.58","article-title":"Survival in primary pulmonary hypertension: the impact of epoprostenol therapy","volume":"106","author":"McLaughlin","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2018.04.014_bib0260","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1253\/circj.CJ-10-0190","article-title":"Marked hemodynamic improvements by high-dose epoprostenol therapy in patients with idiopathic pulmonary arterial hypertension","volume":"74","author":"Akagi","year":"2010","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2018.04.014_bib0265","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jjcc.2015.11.012","article-title":"Rapid and high-dose titration of epoprostenol improves pulmonary hemodynamics and clinical outcomes in patients with idiopathic and heritable pulmonary arterial hypertension","volume":"68","author":"Tokunaga","year":"2016","journal-title":"J Cardiol"},{"key":"10.1016\/j.jjcc.2018.04.014_bib0270","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/art.23303","article-title":"Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases","volume":"58","author":"Jais","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jjcc.2018.04.014_bib0275","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1253\/circj.CJ-15-0599","article-title":"Treat and repair strategy in patients with atrial septal defect and significant pulmonary arterial hypertension","volume":"80","author":"Kijima","year":"2016","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2018.04.014_bib0280","doi-asserted-by":"crossref","DOI":"10.1093\/ehjcr\/yty033","article-title":"Treat-and-repair strategy is a feasible therapeutic choice in adult patients with severe pulmonary arterial hypertension associated with a ventricular septal defect: case series","author":"Akagi","year":"2018","journal-title":"Eur Heart J Case Rep"},{"key":"10.1016\/j.jjcc.2018.04.014_bib0285","first-page":"10","article-title":"Enhanced EP4 expression in a pulmonary artery aneurysm with dissection in a patient with pulmonary arterial hypertension","author":"Akagi","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jjcc.2018.04.014_bib0290","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jjcc.2017.11.005","article-title":"Progression of pulmonary artery dilatation in patients with pulmonary hypertension coexisting with a pulmonary artery aneurysm","volume":"71","author":"Akagi","year":"2018","journal-title":"J Cardiol"},{"key":"10.1016\/j.jjcc.2018.04.014_bib0295","first-page":"50","article-title":"RESPITE: switching to riociguat in pulmonary arterial hypertension patients with inadequate response to phosphodiesterase-5 inhibitors","author":"Hoeper","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jjcc.2018.04.014_bib0300","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.rmed.2017.08.032","article-title":"Efficacy and safety of long-term imatinib therapy for patients with pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis","volume":"131","author":"Ogawa","year":"2017","journal-title":"Respir Med"}],"container-title":["Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508718301370?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508718301370?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T12:59:34Z","timestamp":1760273974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0914508718301370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S0914508718301370"],"URL":"https:\/\/doi.org\/10.1016\/j.jjcc.2018.04.014","relation":{},"ISSN":["0914-5087"],"issn-type":[{"value":"0914-5087","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modern treatment to reduce pulmonary arterial pressure in pulmonary arterial hypertension","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jjcc.2018.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}]}}